Clin Mol Hepatol.
2025 Apr;31(2):e194-e196. 10.3350/cmh.2025.0181.
Correspondence to editorial on “Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive”
- Affiliations
-
- 1Department of Clinical Laboratory, State key Laboratory of Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
- 2Center for bioinformatics, National Infrastructures for Translational Medicine, Institute of Clinical Medicine & Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- 3Department of Rheumatology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
- 4Department of Health Management, Peking Union Medical College Hospital, Beijing, China
- KMID: 2567024
- DOI: http://doi.org/10.3350/cmh.2025.0181
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Is AMA M2 a useful serologic test for screening high-risk patients for PBC?: Editorial on “Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive”
- Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive
- A case of conventional antimitochondrial antibody test-negative primary biliary cirrhosis
- Correspondence to editorial on “Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma”
- Diagnosis and Treatment of Primary Biliary Cholangitis
